Challenge

Premature ejaculation affects millions of men worldwide, yet treatment options were either inaccessible, overly clinical, or intimidating. Momentum Management identified a market opportunity for an FDA-compliant, over-the-counter desensitizing spray that could build consumer confidence while staying within strict regulatory frameworks.

Approach

I led the full product development process, from concept ideation to market launch, balancing pharmaceutical-level compliance with approachable consumer branding. This meant aligning formulation, claims, and marketing language with FDA standards while positioning Dynamo Delay as a performance-enhancing, confidence-boosting solution.

Execution

• Oversaw collaboration between R&D, regulatory consultants, and packaging vendors to develop a compliant, appealing product.

• Designed packaging and messaging that emphasized safety, discretion, and efficacy.

• Developed marketing campaigns (digital, retail, B2B) that normalized the conversation around endurance and intimacy without overstepping compliance.

Results

• Dynamo Delay became a flagship OTC product, surpassing $500M in retail sales globally.

• Established as a market leader in its category, driving international expansion opportunities.

• Created a repeat-purchase product that strengthened consumer trust in the broader brand portfolio.